Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Noiiglutide

A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

Hengrui · Phase 2 · Completed · Enrollment 128

NCT03848793

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
HS-20004 or placebo treatment (Low dose)n/rn/rn/rn/rn/r
HS-20004 or placebo treatment (median dose 1)n/rn/rn/rn/rn/r
HS-20004 or placebo treatment (median dose 2)n/rn/rn/rn/rn/r
HS-20004 or placebo treatment (high dose)n/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.